Isolation and Characterization of Antigen-Specific Plasmablasts Using a Novel Flow Cytometry-Based Ig Capture Assay

Christopher L Pinder1, Sven Kratochvil1, Deniz Cizmeci1

  • 1Division of Medicine, Department of Infectious Diseases, Imperial College London, London W2 1PG, United Kingdom; and.

Insights

A new Ig capture assay (ICA) identifies and sorts antigen-reactive antibody-secreting cells. This flow cytometry method aids in antibody analysis and cloning, offering a viable alternative to ELISpot for vaccine response monitoring.

Area of Science:

  • Immunology
  • Cell Biology
  • Biotechnology

Background:

  • Monitoring antigen-specific antibody responses is crucial for vaccine development and infectious disease research.
  • Existing methods for isolating antibody-secreting cells can be time-consuming and may not provide comprehensive phenotypic data.

Purpose of the Study:

  • To develop and validate a novel flow cytometry-based Ig capture assay (ICA) for identifying and sorting antigen-reactive antibody-secreting cells.
  • To assess the utility of ICA for analyzing plasmablast responses in individuals vaccinated with an HIV envelope protein.
  • To compare the performance of ICA with a conventional B cell ELISpot assay.

Main Methods:

  • Development of a flow cytometry-based Ig capture assay (ICA) utilizing antigen-specific binding.
  • Isolation and sorting of antigen-reactive plasmablasts from peripheral blood mononuclear cells (PBMCs) of HIV-vaccine recipients.
  • Production and validation of antigen-specific antibodies via ELISA.
  • Head-to-head comparison of ICA with B cell ELISpot assay for monitoring plasmablast responses over 42 days.

Main Results:

  • The ICA successfully identified and sorted antigen-reactive plasmablasts from PBMCs of vaccinated volunteers.
  • Antigen-specific antibodies produced from ICA-sorted cells demonstrated verified antigen reactivity via ELISA.
  • ICA performance was comparable to the conventional B cell ELISpot assay in tracking antigen-specific plasmablast responses.
  • ICA facilitated the acquisition of phenotypic information from identified antigen-specific cells.

Conclusions:

  • The Ig capture assay (ICA) is a fast, versatile, and effective tool for single-cell sorting of antigen-reactive antibody-secreting cells.
  • ICA serves as a viable alternative to ELISpot for monitoring early antigen-specific plasmablast responses post-vaccination or infection.
  • The assay's ability to capture phenotypic data and enable downstream applications like B cell sequencing and antibody cloning enhances its utility in antibody repertoire analysis for clinical trials.

Related Concept Videos